HD-OPM Archive
Hashtags

#cardiovasculardisease

58 posts

Each daily yogurt serving linked to 14% lower CVD mortality in a 17-cohort meta-analysis

Feb 16, 2025 · Gokhan Can ♥ 19 · 💬 12 Meat, eggs & dairy

A systematic review and dose-response meta-analysis of 17 cohort studies (896,871 participants) found higher yogurt intake was associated with lower all-cause and cardiovascular mortality, with the largest benefit around 0.5 servings per day and no clear further gain above that. No significant association was seen with cancer mortality. As an observational analysis, it shows association, not causation.

2025 ACC statement: inflammation is actionable in CVD, with universal hsCRP screening

Oct 09, 2025 · Gokhan Can ♥ 15 · 💬 13 Inflammation & CRP

Summarises the 2025 ACC Scientific Statement (JACC) concluding the inflammation-ASCVD link is now clinically actionable. It recommends universal hsCRP screening in primary and secondary prevention alongside cholesterol, notes IL-6 and fibrinogen also predict risk, and says CT perivascular fat attenuation is promising but not routine. It contrasts this with a more cautious 2002 CDC/AHA workshop.

PCSK9 inhibition may slow cardiometabolic aging beyond lowering cholesterol

Dec 21, 2023 · Louis Nervegna ♥ 15 · 💬 11 PCSK9, ezetimibe & newer drugs

Louis highlights a GeroScience open-access review proposing PCSK9 inhibition may ameliorate age-related cardiac and liver pathology, and that a multivariate genome-wide analysis of aging traits identified PCSK9 as a potential drug target for healthy aging. He adds that botanical compounds such as berberine also inhibit PCSK9. The anti-aging role remains an emerging research area.

Flu vaccination linked to lower all-cause mortality, per admin's earlier evidence summary

Dec 14, 2025 · Gokhan Can ♥ 10 · 💬 13 Infections & vaccines

Reminder to get vaccinated, linking an earlier admin post. The shared summary lists the flu vaccine with 11-42% lower all-cause mortality in RCTs and prospective cohorts, 43% lower in consistent associations across 40+ studies, and 25-40% lower Alzheimer's risk, citing a cohort study and a systematic review and meta-analysis. Also notes Novavax (non-mRNA) COVID vaccine is no longer available to him.

Plaque starts in neck and leg arteries decades before the heart; calcium scores miss it

Sep 17, 2026 · Gokhan Can ♥ 17 · 💬 5 Plaque, CAC & CT angiography

The post summarises a video describing an NEJM study of 16,000 asymptomatic people showing plaque accumulates first in the neck and leg arteries, during the 20s to 40s, before the heart. Heart scans such as coronary calcium may therefore miss early disease; carotid intima-media thickness ultrasound can detect peripheral plaque, and the ankle-brachial index offers a simple at-home check for leg artery blockage.

Upcoming RCT will test red wine vs CVD; Louis explains why he drinks mild red wine

Jun 10, 2025 · Louis Nervegna ♥ 17 · 💬 7 Alcohol, smoking & vaping

Louis announces a planned 5-year randomized trial of red wine and cardiovascular disease, run in PREDIMED style by the same principal investigator, with cancer and all-cause mortality as secondary endpoints. Meanwhile he drinks red wine several days a week, citing PREDIMED data where a biomarker of mild-to-moderate wine intake was linked to 50% lower risk. This is a personal view, not proof of benefit.

How LDL causes atherosclerosis: oxidation, inflammation, foam cells and genetics

May 19, 2024 · Gokhan Can ♥ 12 · 💬 9 LDL, ApoB & lipid panel

Explains five lines of evidence for a causal role of LDL in atherosclerosis: oxidized LDL in the artery wall, endothelial dysfunction and inflammation, macrophage foam-cell formation, Mendelian randomization and familial hypercholesterolemia, and the benefit of LDL-lowering therapies. Useful as a mechanism overview for readers who doubt that LDL is a cause rather than a bystander.

Statins work as well in women as men: 27-trial CTT meta-analysis of 174,000 participants

Dec 19, 2023 · Louis Nervegna ♥ 5 · 💬 11 Statins

Louis rebuts the claim that statins are less effective in women using the Cholesterol Treatment Trialists' meta-analysis of 27 randomized trials. Per 1 mmol/L LDL reduction, proportional reductions in major vascular events and all-cause mortality were similar in women and men, with no adverse effect on cancer or non-CV mortality. Trials averaged 4.9 years, so longer-term benefit is likely larger.

REACT: silent atherosclerosis found in 57% of 16,808 adults, 7-9% of 18-29-year-olds

Sep 26, 2026 · Louis Nervegna ♥ 11 · 💬 2 Plaque, CAC & CT angiography

The NEJM REACT study used carotid and femoral ultrasound plus coronary CT angiography in 16,808 adults aged 18-70 without known disease. Plaque was present in 57% overall, appeared in young adults, and a zero calcium score often missed early non-calcified plaque. Ten-year risk scores detected very little silent disease, so keeping risk factors favorable throughout life is the priority.

Statins cause under 10% of reported muscle pain, analysis of 23 RCTs finds

Jun 29, 2026 · Louis Nervegna ♥ 6 · 💬 2 Statins

Louis shares the Oxford/CTT Lancet analysis of 23 large randomized trials (155,000 people) showing muscle pain is common with or without a statin. Over 90% of muscle pain reported on statins was not caused by the drug, and true statin-related cases occurred mainly in the first year, more with high-intensity dosing.

WOSCOPS 20-year follow-up: 5 years of pravastatin gave lasting mortality and event benefit

Apr 07, 2026 · Gokhan Can ♥ 7 · 💬 1 Statins

Describes the 20-year follow-up of the West of Scotland Coronary Prevention Study: 5 years of pravastatin in middle-aged men with high cholesterol and no prior CHD produced a lasting legacy effect, with reduced all-cause, CV and coronary mortality and fewer heart failure and MI hospitalizations. No excess cancer or non-CV mortality was seen.

Bisphosphonates for bone loss: fracture reductions summarized

Oct 13, 2024 · Gokhan Can ♥ 4 · 💬 1 ↩ 1 Hormones, women's & men's health

Review of bisphosphonate evidence for osteoporosis. Alendronate cuts vertebral and non-vertebral fractures by about 50% in women with prior vertebral fractures; yearly IV zoledronic acid cuts vertebral fractures 70% and hip fractures 40%; a 2017 meta-analysis found overall fracture OR 0.62. Not a heart topic but relevant to aging.

Long-term ADHD medication linked to 4% higher CVD risk per year of use

Dec 07, 2023 · Louis Nervegna ♥ 2 · 💬 1 Blood pressure, salt & potassium

Louis shares a report on a JAMA Psychiatry nested case-control study from Karolinska Institutet. Long-term ADHD drug use was associated with 4% greater CVD risk per year of use, with the largest rise in the first three years, in children and adults, females and males. Hypertension and arterial disease drove most of the association, and stimulants were also linked. Observational, so association not proof of causation.

Berberine 500 mg twice daily lowered ApoB in two trials; CVD prevention unproven

Oct 29, 2026 · Louis Nervegna ♥ 1 Supplements & vitamins

A shared summary says two randomized trials of 500 mg berberine twice daily reduced ApoB, with a reduction nearly three times greater in women, though across separate trials. A newer study of 84 men identified a 'Berberine Signature' of 92 proteins linked to about 13% lower odds of ischemic heart disease in UK Biobank, but those participants were not necessarily taking berberine, so it does not prove prevention.